Quartalsergebnisse (Earnings) für Amgen

defenseworld.net2026-10-05 13:55:02

Amgen Inc. $AMGN Shares Purchased by Ferguson Wellman Capital Management Inc.

Ferguson Wellman Capital Management Inc. boosted its holdings in Amgen Inc. (NASDAQ: AMGN) by 4.8% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 259,022 shares of the medical research company's stock after acquiring an additional 11,950 shares during

defenseworld.net2026-10-05 13:07:29

2,546 Amgen Inc. $AMGN Shares Sold by Argent Capital Management LLC

Argent Capital Management LLC lowered its position in shares of Amgen Inc. (NASDAQ: AMGN) by 3.5% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 69,486 shares of the medical research company's stock after selling 2,546 shares during the quarter. Amgen comprises 0.2% of Argent

fool.com2026-10-04 10:14:57

Amgen vs. Vertex Pharmaceuticals: Which Biotech Stock Is a Better Buy in 2026?

Amgen offers a diversified portfolio of established therapies across oncology and inflammation supported by robust cash flow. Vertex Pharmaceuticals maintains a dominant position in the cystic fibrosis market and is expanding into high-growth gene therapies.

zacks.com2026-10-01 18:51:06

Amgen (AMGN) Stock Dips While Market Gains: Key Facts

Amgen (AMGN) closed at $407.27 in the latest trading session, marking a -3.38% move from the prior day.

zacks.com2026-10-01 10:50:59

Lilly vs. Novo: Inside the Milan EASD Showdown and the ETFs Poised to Win

LLY and Novo face off at EASD as new data fuels the GLP-1 market, while ETFs offer diversified exposure to weight loss drug growth.

gurufocus.com2026-09-29 20:12:00

Amgen Inc (AMGN) Shares Surge 1.3% -- What GF Score of 87 Tells Investors

On September 29, 2026, Amgen Inc (AMGN) shares rose 1.3% to a current price of $423.64, within a 52-week range of $274.02 to $447.03. This price movement reflec

247wallst.com2026-09-29 09:03:17

Why Amgen's 6% Dividend Raise Masks a Tougher Road Ahead

Amgen just handed income investors another dividend raise, but a mountain of acquisition debt, crumbling legacy drugs, and a billion-dollar obesity bet are all competing for the same pool of cash.

zacks.com2026-09-28 10:15:35

Take the Zacks Approach to Beat the Markets: Bloom Energy, Microsoft & Amgen in Focus

Microsoft, Bloom Energy and Amgen highlight Zacks' latest market moves, with strong gains across Focus List, recommendation and dividend portfolios.

fool.com2026-09-28 08:00:00

Should You Buy QQQ or VUG Right Now? Here's What History Suggests.

It all comes down to portfolio construction -- one is logical, one isn't.

fool.com2026-09-26 16:01:01

2 Healthcare Stocks That Just Delivered Great News for Investors

Vertex Pharmaceuticals and Amgen recently posted strong clinical trial results for promising candidates. Both companies have robust businesses and strong medium-term prospects.

EPS (USD)

Umsatz (USD)

Revisionen der Gewinnschätzungen